Tweed’s first batch of medical marijuana will be delivered a month later than planned and will be irradiated, the company announced Thursday.
In a statement made May 1st, the Ottawa-based Licensed Producer admitted to falling short of its promise to deliver its first orders by April.
“To date, we have fallen short. Although we targeted April for our first strains to be available, we will not be shipping until May,” reads a post on the company’s website.
“As a new company growing and harvesting our first batches, each step has taken longer than expected – particularly product testing,” it continues.
Tweed, which received a license in January to supply Health Canada’s MMPR program, also announced that it will be irradiating its initial batch. The process, which the company has decided to call “cold pasteurization,” involves exposing the cannabis to low levels of radiation in order to eliminate harmful pests and contaminants.
But many patients are against the practice. Likewise, Tweed took to Twitter to assure those concerned that the company isn’t planning to irradiate future batches.
“Our intention is that it is only the first batch, and that going forward this will not be necessary,” Tweed said.
In Thursday’s statement, the company also said it will be “releasing more and more strains and in increasing volumes” in coming weeks. The company added that it “will likely experience more growing pains,” but promised to continue to be transparent and committed to the highest standards.
Late last month, Tweed was forced to suspend patient registrations due to greater than expected demand. The company said it would be prioritizing access to medical marijuana to customers who had registered or submitted an application before April 21st.
Tweed also announced plans to build more grow rooms in order to increase its production capabilities.